Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 31 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- Brain Oligometastasis in NSCLCActive, not recruitingNCT07389642
- easyEndoTM Powered in Thoracic SurgeryCompletedNCT07353489Not applicable
- Mobilization Before and After Video-Assisted Thoracoscopic Surgery Lobectomy/SegmentectomyCompletedNCT07338474
- The HER Project: HRD in EGFR-mutated NSCLCActive, not recruitingNCT07303218
- Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.Active, not recruitingNCT07274761Phase 2
- Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing FunctionActive, not recruitingNCT07272356Not applicable
- An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung CancerCompletedNCT07271446Phase 1
- Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung CancerCompletedNCT07267247
- Predictive Value of Exosomes in Pleural Effusion for Advanced Lung CancerActive, not recruitingNCT07262671
- Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung CancerActive, not recruitingNCT07259447Not applicable
- Real-Time Non-Invasive Localization for Multiple Lung NodulesCompletedNCT07257549Not applicable
- Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant ImmunotherapyActive, not recruitingNCT07256002
- Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLCCompletedNCT07250360
- Generation of Reactive T Cells Based on Tumor Whole Cell Antigen NanovaccinesActive, not recruitingNCT07239544
- THE EFFECT OF CALISTHENIC EXERCISES ON FATIGUE AND EXERCISE ATTITUDES IN PATIENTS WITH LUNG CANCERActive, not recruitingNCT07237503Not applicable
- Feasibility Testing of a Dyadic Exercise Program for Patients Undergoing Thoracic Radiotherapy and Their Family CaregiversSuspendedNCT07234799Not applicable
- Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%Active, not recruitingNCT07215962
- Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and OutcomesCompletedNCT07215026
- Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.CompletedNCT07213076
- Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the LungActive, not recruitingNCT07202260
- ArticuGrasp Trial: New Flexible Tool vs Standard Grasper for Lung Cancer Node Removal in Keyhole Chest SurgeryCompletedNCT07201077Not applicable
- Body Composition and Inflammatory-Metabolic Indices in Immunotherapy-Treated Metastatic Non-Small Cell Lung Cancer: The SARC-CTI StudyCompletedNCT07192926
- Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLCCompletedNCT07186855
- A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLCActive, not recruitingNCT07183189Phase 3
- A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer ParticipantsActive, not recruitingNCT07180862Phase 1
- Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNCT07162883Phase 3
- A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid TumorsActive, not recruitingNCT07160335Phase 1
- Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer PatientsCompletedNCT07143513
- A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLCCompletedNCT07141563
- Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsTerminatedNCT07121829Phase 1
- A Retrospective Cohort Analysis of SMARCA4-Deficient Lung CancerCompletedNCT07121387
- Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung CarcinomaCompletedNCT07111104
- Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung CancerCompletedNCT07099105
- Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）Active, not recruitingNCT07076693Phase 2/3
- AI-Based Prediction of Stage and Survival in Non-Small Cell Lung Cancer: A Retrospective StudyCompletedNCT07068139
- AI Models for Predicting Occult Pleural Dissemination in NSCLCCompletedNCT07065422
- Tubeless VATS for Lung Cancer SurgeryCompletedNCT07057531Not applicable
- Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLCCompletedNCT07053215Not applicable
- Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRTCompletedNCT07037680Phase 2
- Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1CompletedNCT07036016
- Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of ChemotherapyActive, not recruitingNCT07024862
- A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationActive, not recruitingNCT07023731Phase 1/2
- Interventional Ablation for Early-stage Lung CancerActive, not recruitingNCT07005999
- Factors Determine the Feasibility and Surgical Margin Quality of Sublobar Resection for Non-small Cell Lung Cancer?CompletedNCT07005401
- A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung CancerActive, not recruitingNCT07005336Phase 2
- A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung CancerActive, not recruitingNCT06984588Phase 2/3
- Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to BonesWithdrawnNCT06982222Phase 1
- A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic MalignanciesTerminatedNCT06974734Phase 1
- JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLCActive, not recruitingNCT06969027Phase 2
- Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLCCompletedNCT06958614
- Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With ChemotherapyActive, not recruitingNCT06954259
- A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and RectumCompletedNCT06950996
- A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNCT06946797Phase 2
- Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung CancerWithdrawnNCT06943664Phase 2
- Exploration of Risk Factors for Postoperative Cerebral Infarction in Lung Cancer Patients: a Retrospective Single-centre StudyActive, not recruitingNCT06942845
- Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial TumorsCompletedNCT06939049
- Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung CancerActive, not recruitingNCT06933329Phase 2
- A Clinical Study of Furmonertinib in the Treatment of EGFR-Mutated NSCLC With Leptomeningeal MetastasesActive, not recruitingNCT06926803
- Quality of Life as a Predictor of OS and PFS in Patients With Lung CancerActive, not recruitingNCT06900283
- A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)CompletedNCT06894771Phase 1
- A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLCActive, not recruitingNCT06883630Phase 1
- Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)CompletedNCT06876402
- Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung CarcinomasActive, not recruitingNCT06872541Phase 2/3
- A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersTerminatedNCT06870487Phase 1
- Overcoming Resistance to EGFR Neutralization by Combination of Monoclonal Antibodies and Novel Cancer DrugsActive, not recruitingNCT06863818
- A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung CancerCompletedNCT06863233Phase 1
- Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLCNo longer availableNCT06841874
- Combination of Vebreltinib and Osimertinib in Patients with EGFR 21 L858R Mutation Advanced NSCLCActive, not recruitingNCT06827145Phase 2
- Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLCActive, not recruitingNCT06808113
- A Study of AL8326 in Non-Small Cell Lung CancerActive, not recruitingNCT06794957Phase 1
- XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.Active, not recruitingNCT06792435Phase 1/2
- Safety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsActive, not recruitingNCT06781983Phase 1
- KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid TumorsActive, not recruitingNCT06767046Phase 1
- QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future ExplorationCompletedNCT06766565Phase 1
- Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC PatientsActive, not recruitingNCT06751108
- Real-World Immuno-Radiotherapy for Advanced NSCLCCompletedNCT06747026
- Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in FranceCompletedNCT06735781
- Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung CancerActive, not recruitingNCT06732401Phase 3
- A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid TumorsActive, not recruitingNCT06730750Phase 1/2
- Evaluation of the Efficacy and Safety of Befotertinib Combined With Bevacizumab as First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer With Brain Metastases: A Single-Arm, Open-Label, Prospective Phase II Clinical StudyActive, not recruitingNCT06728865Phase 2
- Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)Active, not recruitingNCT06726265Phase 3
- Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT SystemWithdrawnNCT06722885
- Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid TumorsTerminatedNCT06714617Phase 1
- A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerActive, not recruitingNCT06711900Phase 3
- Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)Active, not recruitingNCT06710132Phase 1/2
- A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.TerminatedNCT06704724Phase 1
- Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation PneumonitisActive, not recruitingNCT06700421Phase 2
- A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)Active, not recruitingNCT06698042Phase 3
- Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)SuspendedNCT06694454Phase 1/2
- A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung CancerTerminatedNCT06685718Phase 1
- A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.CompletedNCT06678555
- Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain MetastasesWithdrawnNCT06676917Phase 2
- Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records DatabasesCompletedNCT06675695
- A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLCActive, not recruitingNCT06671379Phase 3
- A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerActive, not recruitingNCT06670196Phase 3
- Impact of Smoking Cessation Duration on Postoperative Complications in Lung Cancer SurgeryCompletedNCT06663020
- Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung CancerActive, not recruitingNCT06660407Phase 2
- Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung CancerSuspendedNCT06653023Early Phase 1
- EPIC- Extracorporeal Photopheresis (ECP) for Immune-related ColitisWithdrawnNCT06646016Phase 2
- A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic AlterationsActive, not recruitingNCT06644768Phase 1/2